Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Andersen

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Journal of Pharmaceutical Sciences|May 24, 2022
Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human PrimatesKendall B Preston, Teri Ann S Wong, Michael M Lieberman, et al.
Med (New York, N.Y.)|March 22, 2022
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamstersKatherine McMahan, Victoria Giffin, Lisa H Tostanoski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challengeZachary R Sia, Xuedan He, Ali Zhang, et al.
Frontiers in Immunology|September 6, 2021
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg VirusesAxel T Lehrer, Eleanore Chuang, Madhuri Namekar, et al.
Nature Microbiology|August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionJiří Zahradník, Shir Marciano, Maya Shemesh, et al.
NPJ Vaccines|December 21, 2021
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2Ria Lassaunière, Charlotta Polacek, Gregers J Gram, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
ACS Infectious Diseases|March 9, 2022
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) VariantAlbert To, Teri Ann S Wong, Michael M Lieberman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2016
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesDonatella Negri, Maria Blasi, Celia LaBranche, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical Sciences|May 24, 2022
Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80-Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human PrimatesKendall B Preston, Teri Ann S Wong, Michael M Lieberman, et al.
Med (New York, N.Y.)|March 22, 2022
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamstersKatherine McMahan, Victoria Giffin, Lisa H Tostanoski, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challengeZachary R Sia, Xuedan He, Ali Zhang, et al.
Frontiers in Immunology|September 6, 2021
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg VirusesAxel T Lehrer, Eleanore Chuang, Madhuri Namekar, et al.
Nature Microbiology|August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionJiří Zahradník, Shir Marciano, Maya Shemesh, et al.
NPJ Vaccines|December 21, 2021
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2Ria Lassaunière, Charlotta Polacek, Gregers J Gram, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
ACS Infectious Diseases|March 9, 2022
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) VariantAlbert To, Teri Ann S Wong, Michael M Lieberman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2016
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesDonatella Negri, Maria Blasi, Celia LaBranche, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Pageof 14